SARS-CoV-2T:

Martin Qui1, Smrithi Hariharaputran1, Shou Kit Hang1

  • 1Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.

EBioMedicine
|June 19, 2024
PubMed
概括

接种疫苗的5-11岁儿童的混合免疫力增强了对SARS-CoV-2的T细胞反应,反映了成人混合免疫力. 这种针对多个病毒蛋白的免疫反应的多样化提供了对严重的COVID-19的保护.